Skip to main content
CMEducation Resources ScrollCall
  • menu
  • menu
  • person
  • Search
  • Specialty
  • Cardiology chevron_right

  • Specialty Program
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Pain Management chevron_right
  • Glycemic Regulation chevron_right
  • PCSK9s in Interventional Cardiology chevron_right
  • PCSK9s in Medical Preventative chevron_right
  • PCSK9s in Lipid Medicine & Atherosclerosis Prevention chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • PCSK9s: A Multi-Specialty Perspective chevron_right
  • Specialty
  • Diabetes chevron_right

  • Specialty Program
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Glycemic Regulation chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • Specialty Program
  • Congenital Adrenal Hyperplasia (CAH) chevron_right
  • Cytokine Immunotherapy chevron_right
  • Hypothyroidism chevron_right
  • Specialty Program
  • Parkinson's Diseasechevron_right
  • Specialty
  • Cancer chevron_right

  • Specialty Program
  • Cytokine Immunotherapy chevron_right
  • Extracorporeal Photopheresis (ECP) chevron_right
  • Pain Management chevron_right
  • Specialty
  • Primary Care chevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Congenital Adrenal Hyperplasia (CAH) chevron_right
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Parkinson's Diseasechevron_right
  • Pain Management chevron_right
  • Glycemic Regulation chevron_right
  • Specialty
  • Dermatology chevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Cytokine Immunotherapy chevron_right
  • Fabry Disease chevron_right
  • Extracorporeal Photopheresis (ECP) chevron_right
  • Specialty
  • Biologicschevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Cytokine Immunotherapy chevron_right
  • Fabry Disease chevron_right
  • Biosimilars for RA chevron_right
  • PCSK9s in Interventional Cardiology chevron_right
  • PCSK9s in Medical Preventative chevron_right
  • PCSK9s in Lipid Medicine & Atherosclerosis Prevention chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • PCSK9s: A Multi-Specialty Perspective chevron_right
  • Specialty
  • MAC Lung Disease chevron_right

  • Specialty Program
  • MAC Lung Disease chevron_right
    • close
    CMEducation Resources iQ&A
    • person
    • Home
    • Specialtieschevron_right
      • chevron_leftTopics
      • Cardiology
      • Diabetes
      • Endocrinology
      • Neurology
      • Cancer
      • Primary Care
      • Dermatology
      • Biologics
      • MAC Lung Disease
    • Submit A Question
    close

    Maher El Chaar, MD

    Maher El Chaar, MD

    Co-Medical Director of Bariatric Surgery
    St Luke’s University Hospital
    Allentown, Pennsylvania


    Related Videos

    What unique aspects of your trial design do you think are worth emphasizing? What are the take-home messages about the mechanism(s) by which IV acetaminophen reduces indirect costs? Video

    What unique aspects of your trial design do you think are worth emphasizing? What are the take-home messages about the mechanism(s) by which IV acetaminophen reduces indirect costs?

    In summary, what unique aspects of your trial design (J Gastrointest Surg. 2016 Apr;20(4):715-24) do you think are worth emphasizing? And what are the take-home messages about the mechanism(s) by which IV acetaminophen reduces indirect costs?

    Are there are surgical procedures outside the context of bariatric surgery where you think this approach to pain control may provide similar advantages? Video

    Are there are surgical procedures outside the context of bariatric surgery where you think this approach to pain control may provide similar advantages?

    Clearly, your clinical experience has established the efficacy, safety and cost-effectiveness associated with IV acetaminophen in the setting of bariatric surgery, but are there are surgical procedures outside this context where you think ...

    How does the side effect profile of acetaminophen compare with placebo or other non-opioid agents? Video

    How does the side effect profile of acetaminophen compare with placebo or other non-opioid agents?

    How does the side effect profile of acetaminophen compare with placebo or other non-opioid agents?

    Are there situations where you might consider IV acetaminophen as monotherapy, as opposed to its use as a non-opioid agent that is part of a multimodal approach requiring rescue with opioids? Video

    Are there situations where you might consider IV acetaminophen as monotherapy, as opposed to its use as a non-opioid agent that is part of a multimodal approach requiring rescue with opioids?

    Are there any situations where you might consider the use of IV acetaminophen as part of monotherapy for certain surgical procedures, as opposed to its use as a non-opioid foundational agent that is part of a multimodal approach requiring rescue with opioids?

    Do you use IV acetaminophen as part of a standardized protocol or do you select patients you think are appropriate for this approach based on specific criteria? Video

    Do you use IV acetaminophen as part of a standardized protocol or do you select patients you think are appropriate for this approach based on specific criteria?

    Do you use IV acetaminophen as part of a standardized protocol or do you select patients you think are appropriate for this approach based on specific criteria?

    Why is the exclusive use of IV opioids in bariatric surgery patients problematic and why is IV acetaminophen uniquely qualified to be part of multimodal post-operative pain management? Video

    Why is the exclusive use of IV opioids in bariatric surgery patients problematic and why is IV acetaminophen uniquely qualified to be part of multimodal post-operative pain management?

    Why is the exclusive use of IV opioids in bariatric surgery patients problematic and why is IV acetaminophen uniquely qualified to be part of multimodal post-operative pain management?

    Why do bariatric surgery patients represent an ideal patient population for use of IV acetaminophen as a part of multimodal post-operative pain management? Video

    Why do bariatric surgery patients represent an ideal patient population for use of IV acetaminophen as a part of multimodal post-operative pain management?

    Why do bariatric surgery patients represent an ideal patient population for use of IV acetaminophen as a part of multimodal post-operative pain management?

    What are the pharmacoeconomic and "pain management policy" implications of your study evaluating costs and clinical metrics in bariatric surgery patients managed with IV acetaminophen? Video

    What are the pharmacoeconomic and "pain management policy" implications of your study evaluating costs and clinical metrics in bariatric surgery patients managed with IV acetaminophen?

    What are the pharmacoeconomic and “pain management policy” implications of your study evaluating differential costs and clinical metrics in bariatric surgery patients managed with IV acetaminophen? What are the institutional and patient ...

    Did your study show that the group that received IV acetaminophen incurred fewer emergency department visits, hospital readmissions, pain-related complaints, and lower indirect costs? Video

    Did your study show that the group that received IV acetaminophen incurred fewer emergency department visits, hospital readmissions, pain-related complaints, and lower indirect costs?

    Did your study essentially show that even though pain scores did not differ significantly during the post-op 24 hour period between the groups that did and did not receive IV acetaminophen, during the 30-day post-op observation period, ...

    Disclaimer:
    Copyright © by CMEducation Resources, LLC All rights reserved. Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
    Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.
    Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.
    Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

    Clinical Webcasts®

    Powered by BroadcastMedBROADCASTMED